| Application no. and date | 20198371.5 (espacenet) (Federated) (European Patent Register), 20150312 | | Patent/reg. no. and date | DK/EP 3777833, 20231018 | | Publication date | 20210217 | | Priority no. and date | US 201461952477 P, 20140313, US 201461990967 P, 20140509 | | EP pub. no. and date |
EP 3777833 20210217 | | Effective date | | | Applicant/owner | Neuroderm Ltd., Weizmann Science Park
3 Golda Meir Street
7403648 Ness Ziona, IL | | Applicant ref. no. | BB236972EPDK | | Inventor | YACOBY-ZEEVI, Oron, 204 Hanarkissim Street
6094600 Bitsaron, IL | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/133 (2006.01) , A61K 31/198 (2006.01) , A61K 47/18 (2017.01) , A61K 47/20 (2006.01) , A61K 47/22 (2006.01) , A61K 9/00 (2006.01) , A61P 25/16 (2006.01) | | Title | DOPA-DECARBOXYLASE-INHIBITORSAMMENSÆTNINGER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
